| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.06 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |